The deal size was increased to $65M from $50M and priced at low end of $10.00-$10.50 target range. JPMorgan and Evercore ISI are acting as joint book running managers for the offering.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTA:
- Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
- Enanta $50M Spot Secondary; price range $10.00-$10.50
- Enanta announces $50M common stock offering
- Promising Phase 2b Trial Results for Enanta Pharmaceuticals’ Zelicapavir Boost Buy Rating and $20 Price Target
- Enanta Pharmaceuticals Announces Positive Phase 2b Results